Nanocomposite particles with improved microstructure for 3D culture systems and bone regeneration
Sergiu Cecoltan1, Izabela-Cristina Stancu2,3, Diana Maria Drăguşin1,4
1Advanced Polymer Materials Group, Faculty of Applied Chemistry and Materials Science, University POLITEHNICA of Bucharest, 1-7 Gheorghe Polizu Street, Sector 1, 011061, Bucharest, Romania.
Journal of Materials Science. Materials in Medicine
|September 2, 2017
Summary
Bio-inspired nano-apatite and gelatin-alginate hydrogel microparticles were developed for bone defect reconstruction. The 7.5P formulation demonstrated superior in vitro performance and promoted new bone formation in vivo.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Nanotechnology
Background:
- Bone defects require advanced regenerative strategies.
- Nano-apatite-biopolymer composites offer potential for bone regeneration.
- Microstructural optimization of mineral distribution and stability remains a challenge.
Purpose of the Study:
- To develop bio-inspired nano-apatite and gelatin-alginate hydrogel microparticles for bone defect reconstruction.
- To optimize microparticle formulation for enhanced bone regeneration.
- To evaluate the in vitro and in vivo performance of the developed microparticles.
Main Methods:
- One-step synthesis combined with electrostatic bead generation for microparticle fabrication.
- In situ synthesis of nano-apatite within a crosslinked hydrogel matrix.
- In vitro evaluation of osteolytic potential, cytocompatibility (MC3T3-E1 cells), and comparison with a commercial bone graft substitute (Eurocer 400).
- In vivo biocompatibility assessment in a critical-size rabbit bone defect model.
Main Results:
- Two formulations (15P and 7.5P) with varying phosphate content were developed.
- The 7.5P formulation exhibited the best in vitro performance.
- In vivo studies showed newly formed bone in proximity to 7.5P microparticles after 28 days in a rabbit critical-size defect.
Conclusions:
- The developed bio-inspired nano-apatite hydrogel microparticles show promise for bone defect regeneration.
- The 7.5P formulation is a promising candidate for bone tissue engineering applications.
- Further investigation into the long-term efficacy and mechanisms of action is warranted.
